New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 11, 2014
08:56 EDTPIPPharmAthene price target raised to $6 from $4 at Aegis
Aegis raised Buy rated PharmAthene's (PIP) price target to $6 following the Delaware Court's ruling entitling it to lump sum damages from SIGA Technologies (SIGA).
News For PIP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 13, 2015
08:11 EDTPIPPharmAthene receives $5.8M payment from BARDA
PharmAthene announced that on April 9 it received from the Biomedical Advanced Research and Development Authority, or BARDA, a one-time payment of $5.8M related to the reconciliation between the actual and the provisional rates on the performance of the SparVax contract for the years 2008 through 2013 for actual costs incurred during that period. The contract ended on February 28

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use